Synlogic announced that it has entered into an approximately $1M subcontract under an Air Force Research Lab, or AFRL, prime contract to develop a manufacturing process to support development of a potential live probiotic product. The grant is an extension of work initiated by Synlogic in 2020 as part of the Air Force Synthetic Biology Challenge with the Massachusetts Institute of Technology. Synlogic’s activities on this project are expected to start in Q1 2024 and will be complete in Q1 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SYBX:
- Synlogic initiated with bullish view at Alliance Global Partners, here’s why
- Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Synlogic expects cash to fund operations into 1H25
- Synlogic reports Q3 EPS ($2.57), consensus ($2.67)
- Synlogic achieves research milestone, earns $2.5M milestone payment
